MSLN and mesothelioma: Since the anti-mesothelin (5B2 and MN-1) antibodies offered a superior signal quality in a preliminary study, they were used to analyze 1562 tumors to compare immunoreactivities of selected tumors as well as to test their clinical utility for pathological diagnosis and prognostication of mesothelioma patients.